ArticleTherapeutics and clinical risk management2018

Effects of denosumab on bone metabolism and bone mineral density with anti-TNF inhibitors, tocilizumab, or abatacept in osteoporosis with rheumatoid arthritis.

Takako Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.